Archive for the ‘Digestive’ Category

h1

Heath Hazards of Herbicide “Roundup”

January 30, 2011

Quote from Roundup Researcher: “If I know something, I will not shut my mouth.”

Dr. Andrés Carrasco, an embryologist who works in Argentina’s Ministry of Science’s Conicet (National Council of Scientific and Technical Investigations) responding to criticism over his research which found that Monsanto’s Roundup herbicide caused brain, intestinal and heart defects in amphibian fetuses.

[Note: main ingredient in Roundup = glyphosate.]

Scientist Warning of Health Hazards of Monsanto’s Herbicide Receives Threats

“I expected a reaction but not such a violent one”

In April 2009 Andrés Carrasco, an Argentinian embryologist, gave an interview to the leading Buenos Aires newspaper Página 12, in which he described the alarming results of a research project he is leading into the impact of the herbicide glyphosate on the foetuses of amphibians. Dr Carrasco, who works in the Ministry of Science’s Conicet (National Council of Scientific and Technical Investigations), said that their results suggested that the herbicide could cause brain, intestinal and heart defects in the foetuses. Glyphosate is the herbicide used in the cultivation of Monsanto’s genetically modified soya, which now covers some 18 million hectares, about half of Argentina’s arable land. [1]

Carrasco said that the doses of herbicide used in their study were “much lower than the levels used in the fumigations”. Indeed, as some weeds have become resistant to glyphosate, many farmers are greatly increasing the concentration of the herbicide. According to Página 12, this means that, in practice, the herbicide applied in the fields is between 50 and 1,540 times stronger than that used by Carrasco. The results in the study are confirming what peasant and indigenous communities – the people most affected by the spraying – have been denouncing for over a decade. The study also has profound consequences for the USA’s anti-narcotics strategy in Colombia, because the planes spray glyphosate, reinforced with additional chemicals, on the coca fields (and the peasants living among them).

Three days after the interview, the Association of Environmental Lawyers filed a petition with the Argentine Supreme Court, calling for a ban on the use and sale of glyphosate until its impact on health and on the environment had been investigated. Five days later the Ministry of Defense banned the planting of soya in its fields. This sparked a strong reaction from the multinational biotechnology companies and their supporters. Fearful that their most famous product, a symbol of the dominant farming model, would be banned, they mounted an unprecedented attack on Carrasco, ridiculing his research and even issuing personal threats. He was accused of inventing his whole investigation, as his results have not yet been peer-reviewed and published in a prestigious scientific journal.

According to an article in the Argentine press, after news about the study broke, Dr. Carrasco was the victim of an act of intimidation, when four men arrived at his laboratory in the Faculty of Medicine and acted extremely aggressively.

Two of the men were said to be members of an agrochemical industry body but refused to give their names. The other two claimed to be a lawyer and notary. They apparently interrogated Dr. Carrasco and demanded to see details of the experiments. They left a card Basílico, Andrada & Santurio, attorneys on behalf of Felipe Alejandro Noël.

Carrasco was firm in his response: “When one is dealing with a subject of limited public interest, one can keep the study secret until all the last details have been resolved. But when one uncovers facts that are important for public health, one has an obligation to make an effort to publish the results urgently and with maximum publicity.” Even so, he was clearly taken aback by the strength of the reaction. “It was a violent, disproportionate, dirty reaction”, he said. “I hadn’t even discovered anything new, only confirmed conclusions that others had reached. One has to remember, too, that the study originated in contacts with communities that have suffered the impact of agro-chemicals. They are the undeniable proof of the impact.” He is not intimidated: “If I know something, I will not shut my mouth.”

[1] See: GRAIN, Twelve Years of GM Soya in Argentina – a Disaster for People and the Environment, Seedling, January 2009.

http://www.grain.org/seedling/?id=618

http://www.organicconsumers.org/articles/article_18944.cfm

h1

Sick Building Syndrome

January 29, 2011
Published on Monday, March 30, 2009 by CommonDreams.org

 

Sick Building Syndrome: Floods, Mold, Cancer, and the Politics of Public Health

by Ritt Goldstein

It’s spring, and flooding is again making headlines, although the ‘sick building’ and mold dangers following in flooding’s wake are becoming better appreciated. But disturbingly highlighting the imperatives of such awareness, recently published research has – for the first time – shown the high cost of what the sickness that comes of ‘sick buildings’ can mean, with the potential for long-lasting disability now being a documented fact.

According to a ground breaking Swedish study appearing in The International Archives of Occupational and Environmental Health, 45% of so-called ‘Sick Building Syndrome’ (SBS) victims – treated at hospital clinics – no longer have the capacity to work. Twenty percent of these sufferers are receiving disability pensions, 25% are “on the sick-list”. Emphasizing SBS’s devastating potential, the study warned that the possibilitiy “of having no work capabilities at follow up was significantly increased if the time from (SBS) onset to first visit at the hospital clinic was more than 1 year. This risk was also significantly higher if the patient at the first visit had five or more symptoms.”

It’s unfortunate that knowledge of the serious nature of SBS has not emerged sooner. But, as highlighted by the US Department of Veteran’s Affairs during last Fall’s revelations upon Gulf War Illness, sometimes political and economic considerations affect health policy, leading to a serious health issue long being “denied” or “trivialized”.

‘Sick Building Syndrome’ (more precisely termed ‘non-specific building-related illness’) is typically a product of breathing indoor-air contaminated by mold and/or chemical toxins. Things such as flooding, or poor building contruction, design, or ventilation, can bring on the problem.

SBS’s symptoms have been known to include: mucus-membrane irritation, neurotoxic effects, respiratory symptoms, skin symptoms, gastrointestinal complaints, and chemosensory changes. And while the malady has been increasingly seen since the 1970′s, when energy concerns led to the reduction of indoor ventilation by as much as two thirds, the Swedish study is thought to be the first where the problem has been demonstrated as a chronic condition sparked by environmental causes.

The study was performed by scientists at the Academic Hospital of the University of Umeå, in Northern Sweden, and was based upon locally derived data. But while differences in disability laws and culture may exist between any two nations, as the study strongly observed: “symptoms aggravated by environmental factors exist within this group of patients”.

Providing an interesting parallel, in the aftermath of Hurricane Katrina the New Orleans area saw the phenomenon of ‘Katrina Cough’ occur; a phenomenon marked by a number of SBS symptoms. Though Louisiana health authorities have been dismissive of the ‘Cough’, at present Tullane University School of Medicine has received funding for a five-year study, Tullane’s newspaper headlining: “Researcher Seeks Truth About ‘Katrina Cough’”.

Unfortunately, even problems more serious than SBS can occur through mold, the US Environmental Protection Agency’s (EPA) website explicitly warning that the inhalation of mycotoxins (toxins naturally occurring in some species of molds) has been reported to cause maladies that include cancer. Illustrating what this can mean, recent Swedish headlines shocked the Scandinavian Peninsula with news of just such a cancer outbreak.

Strömbackaskola, a high school in the Northern city of Piteå, was the scene of the cancer cluster. In the worst affected area, about 40% of the employees have been stricken with the disease, with the local paper headlining “The mold in the school is cancer causing”, a national headline reading “Mold in school gives teachers cancer”.

Though the cancer cases began appearing years ago, and its cause was earlier investigated, it was only recently that ‘toxic black mold’, Stachybotrys, was found in the affected areas.

Perhaps even more disturbing, while some claim tragedies like this are unforeseeable, others see them born of a misguided defense of past mistakes, with indifference, and even occasional tactics of intimidation, nurturing tragedy. No land is immune to the temptations of politics and economics…and no land is immune to cancer.

As early as 1999, findings of an association between inhaled mycotoxins (such as aflatoxin) and cancer were reported by the National Institute for Occupational Safety and Health (NIOSH), their study noting: “Several studies have provided evidence for the association of cancer in humans with inhalation of aflatoxin contaminated dust, e.g., lung cancer or colon cancer…elevated risks for liver cancer and cancers of biliary tract”. Similar to the EPA, the NIOSH study further warned: “Diseases associated with inhalation of fungal spores include toxic pneumonitis, hypersensitivity pneumonitis, tremors, chronic fatigue syndrome, kidney failure, and cancer.”

It is regrettable that one can only speculate upon what the true incidence of mold-related cancer, and other mycotoxin-related illness, may be, both in the US and abroad.

While an American, I live in Sweden and have for the last twelve years. Perhaps because Sweden isn’t a large nation, Swede’s social activism, their relationship with their government, communities, and each other, is considerably stronger than that I once knew. But, despite this…

In an article published this summer upon Sweden’s ‘sick schools’ – in Scandinavia’s largest daily, Aftonbladet – I had emphasized that mold can indeed cause maladies ranging from asthma to cancer. But as early as 1997, Stockholm’s papers were already broaching questions of ‘sick building’ related cancers, questions which seem to have been ignored.

At that time, Swedish toxicologist Tony Kronevi was widely quoted as warning of a potential “cancer explosion” resulting from “sick buildings in Sweden”. He specifically warned of problems with “sick schools”, urging that people take “this problem seriously. Now.”

It’s unfortunate that, despite such warnings, this past summer a Swedish government report revealed that those at the national level had yet to take sick schools “seriously.” Just months later, in December, news of the cancer cluster broke.

Was this an instance of political and economic considerations affecting health policy? Was a serious health threat long “denied” or “trivialized”?

Further highlighting what some here have termed ‘indifference’, Swedish parliamentarian Jan Lindholm (Green Party) observed that, for him, it’s “totally inconceivable that the government shows no interest in finding out how over 20 people in a workplace (Strömbackaskola) came to be smitten by cancer”. He added, “this Government is the landlord’s government.”

Approximately a week before news of Strömbackaskola’s cancer outbreak broke, the Swedish Minister for Public Health told Swedish National Radio that she believed the link between poor indoor air and poor health was too weak to act upon.

Reflecting the Minister’s position, Sweden’s governmental websites lack the kind of mold and ‘sick building’ warnings provided by entities such as the EPA and NIOSH, despite the recent SBS findings from Umeå and similar pronouncements from other scientists. Given this, it’s particularly unfortunate that the very young are those most at risk from indoor air problems.

Last Fall I interviewed one of America’s leading authorities on mold – Dr. Dorr Dearborn, Chairman of the Department of Environmental Health Sciences at Case Western Reserve University School of Medicine. Dearborn came to national attention in 1997, The New York Times headlining “Infants’ Lung Bleeding Traced to Toxic Mold”, a revelation he was instrumental in bringing forward. Though his findings and those of his equally courageous colleague, Ruth Etzel, became the subject of considerable debate, the EPA’s “Children’s Health Initiative on Toxic Mold” continues to warn: “A cluster of cases of acute pulmonary hemorrhage/hemosiderosis was reported in Cleveland, Ohio, where 27 infants from homes that suffered flood damage became sick (nine deaths) with the illness starting in January 1993.”

In the interim since his and Dr. Etzel’s findings, animal studies continue to provide ever added confirmation of their conclusions upon toxic mold’s dangers.

During the course of my interview with Dearborn, I asked what had occurred that took the momentum from the ‘sick building’ and mold reforms which many then saw on the horizon. Emphasizing he could just speculate upon what factors had earlier impacted America’s ‘mold debate’, Dearborn spoke of “pressure from industrial sources – insurance companies, etc – to ‘back off’ this problem.”

In Sweden, people have spoken of the “gigantic costs” which addressing ‘sick buildings’ would entail, and this has led many to rationalize away inaction accordingly. Of course, the costs of the widespread illnesses and property damage associated with ‘sick buildings’ is thought to be even more substantive, though, far less visible and borne mainly by individuals, not business or government.

I won’t point out that discussion of isolated cancer cases associated with sick buildings has barely begun here. Nor will I speculate upon the fate of those living in places like Herrgården, a large housing complex in Sweden’s southern city of Malmö’s Rosengård area, where – contrary to the Country’s ‘squeaky clean’ image – recent news stories revealed that half of the apartments are mold infested.

An interview with a number of Rosengård’s healthcare workers recently appeared in local media. The ongoing tragedy they described isn’t pretty.

Within the last twelve months, this nation of nine million has had at least three major residential housing scandals, each involving large numbers of families. And while roach infested slums have sadly now come to Sweden, two of the three scandals involved upscale developments – one was a community of villas on the Country’s west coast, the other was waterside condos in Stockholm.

Of course, in the US, comedic icon Ed McMahon won a $7 million dollar judgment following his Beverly Hills home’s mold problems. But just this March, the TV news program ‘Inside Edition’ ran a story titled: “Did Mold Cause Ed McMahon’s Life-Threatening Cancer?”

In Sweden, the widespread failure to adequately enforce safe-housing laws has been described as an ‘open secret’. In The States, the phrase ‘managed debate’ is used to describe the process through which better regulation of ‘sick buildings’ and mold is kept from even becoming law.

Both circumstances have a cost, and public health has paid dearly. Is Sweden’s mold-associated cancer unique, or rather, is it unique only in that this instance of mold-associated cancer was so large that it could not be rationalized away, dismissed and ignored?

In a November article of mine – which was also published in Aftonbladet – I compared Sweden’s ‘sick building’ scandal to that of China’s melamine. Both scandals are the product of what have been described as ‘open secrets’, but according to a 2003 Swedish survey, sick buildings are sickening a vastly higher population percentage than melamine did.

While our globe is currently witnessing the havoc which lax regulation and unconscionable behavior meant for the financial markets, is this but one indicator of something ‘deeper’? America’s ongoing prescription drug and food scandals, China’s melamine, and Sweden’s ‘sick building’ scandal – all suggest that our ‘crisis’ may be considerably broader than merely one of finance.

History has long demonstrated the high price of blind, ruthless ambition, a price which our world has perhaps only begun to realize it is now paying. Quoting Swedish parliamentarian Jan Lindholm, “totally inconceivable” well describes present circumstances.

We have a problem, a bad problem, and it has its causes. In example, Kronevi told me of a Swedish book he participated in on building issues, a book which might have started vigorous ‘sick building’ debate years ago. He also provided copies of correspondence highlighting how the text had been effectively suppressed.

Of course, a passage from that book noted that a number of Swedish cities, “have noticed an unusually high number of cancer cases connected to SBS symptoms”, with other passages equally interesting. What is also ‘interesting’ are others who have described abuses of power, the efforts to stifle critical voices.

In 2004 I interviewed a number of leading US scientific figures, doing so while writing an exposé series on the drug industry. One article, “Intimidation, Politics and Drug Industry Cripple U.S. Medicine”, contained several interviews worth revisiting.

Kathleen Rest, executive director of the Union of Concerned Scientists (UCS) – whose membership is comprised of much of the cream of America’s scientific community, including a number of Nobel laureates – told me of a “pattern”, a pattern of “politicizing or manipulating scientific advisory boards.” She also noted the UCS had found “evidence and cases of agencies manipulating or suppressing scientific analysis.”

Dr. David J. Graham, the courageous Associate Safety Director of the US Food and Drug Administration (FDA), separately added that “intimidation of scientists who threaten the status quo at FDA is routine.”

It was just this summer when a Swedish environmental researcher – who spoke only under condition of anonymity – told me that challenging the Swedish status quo on ‘sick building’ issues was almost like challenging the mafia. Other Swedes, from different perspectives, have spoken similarly. Leif Kåvestad – a former environmental inspector who received a personal award from the then Swedish Prime Minister, Göran Persson – is one of these.

Both Kåvestad and the researcher indeed described efforts aimed at intimidation, efforts sometimes undertaken by those pursuing self-serving denials of Swedish indoor-environment problems.

On a local level, Kåvestad spoke of how “community Health Departments often cooperate with the community housing companies and their consultants. Tenants which complain over sick buildings with health complaints are threatened…the parties together act like a mafia against the tenants.” And while speaking generally, he added he’s aware of this pattern at some of Stockholm’s ‘sick buildings’, and as an ombud has just taken the question before the Environmental Court.

There is good reason to believe that such circumstances are not limited to Sweden.

An SBS victim myself, I have just filed a civil suit against my landlord, Kopparstaden, a housing firm within the Swedish county of Dalarna. In 2007, my community’s health department declared the apartment Kopparstaden had recently rented me to be uninhabitable.

To this day, my health remains shattered – I suffer a particularly nasty form of SBS.

When I arrived here, as a newcomer to the community, the local ‘Integration Authority’ had offered me the flat. Though it had an unusual odor from the first time I saw it, I was told the odor would ‘disappear’ when I used the plumbing.

When I asked to see other apartments, I was told by the Integration Authority that the apartment was ‘fine’, that there were no others, and, if I didn’t accept it, I wouldn’t be offered another and would likely not find any apartment on my own. Given the circumstances, and that I had no reason to then disbelieve the assurances I was given, I took the flat accordingly.

Later, laboratory analysis revealed “powerfully elevated” mold levels and “unusually high levels” of chemical toxins – such as chloroform – were in every breath I took. According to my physicians, virtually all of my belongings must be disposed of because of contamination, and my insurance policy – as with most insurance policies today – does not cover this kind of claim. However, Kopparstaden’s only compensation offer for my ruined property and shattered health was about $1,000. I refused it.

It is difficult for me to reconcile the many instances I’ve witnessed demonstrating Swedish society’s honesty and integrity with the circumstances I describe.

While the US civil court system has awarded a number of ‘sick building’ and mold sufferers millions of dollars in damages, such things do not exist in this country – there are no punitive damages in this legal system, court awards are ‘minimal’. And, despite such circumstances accentuating the need for robust enforcement of safe housing laws, the opposite appears to have occurred. But, this does well illustrate how the costs of ‘sick buildings’ – though extremely substantive – are today borne mainly by individuals, not the businesses which provide ‘sick’ properties, nor the governmental entities which allow them to continue doing so.

Is today’s ‘crisis’ far broader than merely finance? Has Public Health been sacrificed for political and economic motives?

While many have indeed called the widespread compromising and failure of regulatory authorities an ‘open secret’, perhaps ‘national catastrophe’ may well prove itself a far better term.

LINKS YOU MAY CARE TO USE
© 2009 Ritt Goldstein

Ritt Goldstein (ritt1997@hotmail.com) is an American investigative political journalist based in Stockholm. His work has appeared in broadsheets such as Australia’s Sydney Morning Herald, Spain’s El Mundo and Denmark’s Politiken, as well as with the Inter Press Service (IPS), a global news agency.

h1

Digestive Diseases

January 29, 2011

NIH report finds costs of digestive diseases has grown to more than $141 billion a year

More research funding is needed to support new preventive, diagnostic and treatment strategies

http://www.eurekalert.org/pub_releases/2009-02/aga-nrf021009.php

Bethesda, MD (February 10, 2009) – Digestive, liver and pancreatic diseases result in more than 100 million outpatient visits and 13 million hospitalizations annually at a cost of $141.8 billion. A new report commissioned by the National Institutes of Health finds that costs, doctor visits, prescription costs and hospitalizations related to digestive diseases have risen significantly in recent years. The Burden of Digestive Diseases in the United States report is summarized in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

“This report gives us the best recent update on the toll digestive diseases exact on patients and society – and there are both positive and negative trends,” said James E. Everhart, MD, MPH of the Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, and lead author of the study. “While deaths from digestive diseases have gradually declined over the last 25 years, they still result in more than 230 thousand deaths per year. Some diseases stand out in significance. For example, outpatient visits and hospitalizations for gastroesophageal reflux disease increased several fold in the last 15 years with a corresponding increase in the incidence of its complication of esophageal cancer.”

Notable findings include:

  • Doctor visits increased more than 50 percent since 2000 (100M in 2004; 45M in 2000).
  • Hospitalizations exceeded 13 million in 2004 (up >4M since 2002).
  • Indirect costs1 more than doubled since 1998 ($20B in 1998; $44 B in 2004).
  • Direct costs2 topped $97 billion in 2004, up from $85 billion in 1998.
  • Deaths related to digestive diseases gradually declined between 1979 and 2004 (236 M), which is largely attributable to a decrease in colorectal cancer mortality due to increased screening rates.
  • Nearly 136 million prescriptions have been written for digestive diseases, costing more than $12 billion.

According to the report, the 10 most costly digestive diseases in both direct and indirect costs are:

  1. Digestive cancers: $24.1 billion [$9.5 billion cost of colorectal cancer, $4.3 billion cost for pancreatic cancer are included in the digestive cancers total]
  2. Liver disease: $13.1 billion
  3. Gastroesophageal reflux disease (GERD): $12.6 billion
  4. Gallstones: $6.2 billion
  5. Abdominal wall hernia: $6.1 billion
  6. Diverticular disease: $4.0 billion
  7. Pancreatitis: $3.7 billion
  8. Viral hepatitis (A, B, C): $3.3 billion
  9. Peptic ulcer disease: $3.1 billion
  10. Appendicitis: $2.6 billion

The Burden of Digestive Diseases in the United States is part of the National Commission on Digestive Diseases at the NIH. The AGA worked with our champions in Congress to propose the Commission, which was established to enhance research on digestive diseases for the benefit of patients and their families. The Commission has conducted an overview of the state of the science in digestive diseases research and is developing a 10-year plan for digestive diseases research. Implementing the recommendations of the National Commission on Digestive Diseases is one of the AGA’s highest research priorities. AGA encourages NIH to convene an oversight body and to develop an estimated ‘professional judgment budget’ for implementation of the Commission’s long-range plan for digestive disease research.

“This report quantifies the substantial and growing burden of digestive diseases on patients and our health- care system. There is a tremendous need for more research into the causes, diagnosis and treatment of digestive diseases,” according to Robert S. Sandler, MD, AGAF, president of the AGA Institute. “At the same time, the report identifies conditions that are costly but understudied such as diverticular disease and appendicitis where there is a high burden but little research.”

###

The AGA provides guides for patients suffering from digestive diseases at www.gastro.org/patient.
The complete Burden of Digestive Diseases Report can be found at http://www2.niddk.nih.gov/AboutNIDDK/ReportsAndStrategicPlanning/BurdenofDisease/DigestiveDiseases.

1 Indirect costs are comprised of the implicit value of forgone earnings or production owing to consumption of hospital or ambulatory care, premature death and additional work loss associated with acute and chronic digestive diseases as well as the value of leisure time owing to morbidity and mortality.

2 Direct costs for digestive diseases include charges for hospital services, physician services, prescription drugs, over-the-counter drugs, nursing home care, home health care, hospice care and outpatient endoscopy.

About the AGA Institute

The American Gastroenterological Association (AGA) is dedicated to the mission of advancing the science and practice of gastroenterology. Founded in 1897, the AGA is one of the oldest medical-specialty societies in the U.S. Comprised of two non-profit organizations—the AGA and the AGA Institute—our more than 16,000 members include physicians and scientists who research, diagnose and treat disorders of the gastrointestinal tract and liver.

The AGA, a 501(c6) organization, administers all membership and public policy activities, while the AGA Institute, a 501(c3) organization, runs the organization’s practice, research and educational programs. On a monthly basis, the AGA Institute publishes two highly respected journals, Gastroenterology and Clinical Gastroenterology and Hepatology. The organization’s annual meeting is Digestive Disease Week®, which is held each May and is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. For more information, please visit www.gastro.org.

About Gastroenterology

Gastroenterology, the official journal of the AGA Institute, is the most prominent scientific journal in the specialty and is in the top 1 percent of indexed medical journals internationally. The journal publishes clinical and basic science studies of all aspects of the digestive system, including the liver and pancreas, as well as nutrition. The journal is abstracted and indexed in Biological Abstracts, CABS, Chemical Abstracts, Current Contents, Excerpta Medica, Index Medicus, Nutrition Abstracts and Science Citation Index. For more information, visit www.gastrojournal.org.

Follow

Get every new post delivered to your Inbox.